Literature DB >> 11071964

An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.

T Miyazaki1, I Aoyama, M Ise, H Seo, T Niwa.   

Abstract

BACKGROUND: An oral adsorbent (AST-120) delays the progression of chronic renal failure (CRF). The aims of the present study are to determine the effects of AST-120 on the localization of indoxyl sulphate in uraemic rat kidneys, and to examine whether AST-120 reduces the renal cortical gene expression of transforming growth factor (TGF)-beta1, tissue inhibitor of metalloproteinase (TIMP)-1 and pro-alpha1(I)collagen, and ameliorates glomerular and tubulointerstitial injuries in uraemic rats.
METHODS: Two weeks after 5/6-nephrectomy, 10 rats were divided into pairs such that both rats in each pair exhibited almost the same levels of serum creatinine, blood urea nitrogen and creatinine clearance. One rat from each pair was assigned to a control uraemic group, the other to a uraemic group which received AST-120 everyday for 11 weeks. The localization of indoxyl sulphate was studied by immunohistochemistry using a monoclonal anti-indoxyl sulphate antibody we had developed. The renal cortical gene expression was studied by using northern blotting.
RESULTS: Rats treated with AST-120 showed decreased levels of serum creatinine, blood urea nitrogen and urinary protein as well as increased levels of creatinine clearance as compared with control uraemic rats. AST-120 markedly decreased indoxyl sulphate levels in both serum and urine. Immunohistochemistry demonstrated that indoxyl sulphate was localized in the renal proximal tubular epithelial cells, especially of dilated tubules, and that AST-120 markedly reduced the tubular staining of indoxyl sulphate. AST-120 attenuated interstitial fibrosis, tubular injury as well as glomerular sclerosis, and reduced the renal gene expression of TGF-beta1, TIMP-1 and pro-alpha1(I)collagen.
CONCLUSIONS: AST-120 reduces the gene expression of TGF-beta1, TIMP-1 and pro-alpha1(I)collagen in the kidneys, and delays the progression of CRF, at least in part, by alleviating the overload of indoxyl sulphate on remnant proximal tubular epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071964     DOI: 10.1093/ndt/15.11.1773

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  28 in total

1.  Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate.

Authors:  E Banoglu; G G Jha; R S King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

2.  A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Authors:  Ran-Hui Cha; Shin Wook Kang; Cheol Whee Park; Dae Ryong Cha; Ki Young Na; Sung Gyun Kim; Sun Ae Yoon; Sang Youb Han; Jae Hyun Chang; Sue K Park; Chun Soo Lim; Yon Su Kim
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 8.237

Review 3.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

4.  Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure.

Authors:  Shuji Iida; Keisuke Kohno; Junko Yoshimura; Seiji Ueda; Michiaki Usui; Hiroshi Miyazaki; Hidemi Nishida; Kiyoshi Tamaki; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

5.  Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats.

Authors:  Tsuneo Deguchi; Yousuke Kouno; Tetsuya Terasaki; Akira Takadate; Masaki Otagiri
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

6.  Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure.

Authors:  Seiji Ueda; Sho-ichi Yamagishi; Masayoshi Takeuchi; Keisuke Kohno; Ryo Shibata; Yuriko Matsumoto; Utako Kaneyuki; Toshiko Fujimura; Ayako Hayashida; Seiya Okuda
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

7.  Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure.

Authors:  Kazufumi Iwata; Hiroshi Watanabe; Takafumi Morisaki; Takanobu Matsuzaki; Takafumi Ohmura; Akinobu Hamada; Hideyuki Saito
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

Review 8.  The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective.

Authors:  Paula Mosińska; Martin Storr; Jakub Fichna
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409

Review 9.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

10.  Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats.

Authors:  Takafumi Morisaki; Takanobu Matsuzaki; Koji Yokoo; Masahiro Kusumoto; Kazufumi Iwata; Akinobu Hamada; Hideyuki Saito
Journal:  Pharm Res       Date:  2008-07-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.